Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Diagnosis of nonischemic cardiomyopathy is a challenging process that influences patient morbidity and mortality. Currently, the well known World Health Organization classification has been revisited by an American Heart Association expert consensus panel. The contemporary classification is compatible with the rapid evolution in molecular genetics and evolving diagnostic tools such as cardiac magnetic resonance imaging (MRI). Magnetic resonance imaging is a robust diagnostic tool that offers various techniques to assess the function, morphology, perfusion, and scarring of myocardial tissue thus providing better understanding of the underlying causes of nonischemic cardiomyopathies. In this review, we discuss the current role of cardiac MRI in the evaluation of nonischemic cardiomyopathy, in the context of the current American Heart Association classification of these disorders.
Shehata
Monda L
ML
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Turkbey
Evrim B
EB
Vogel-Claussen
Jens
J
Bluemke
David A
DA
D019571:Arrhythmogenic Right Ventricular Dysplasia / Q000175:diagnosis; D009202:Cardiomyopathies / Q000175:diagnosis*; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis; D002313:Cardiomyopathy, Restrictive / Q000175:diagnosis; D002598:Chagas Cardiomyopathy / Q000175:diagnosis; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging / Q000379:methods; D019028:Magnetic Resonance Imaging, Cine / Q000379:methods*; D008297:Male; D009206:Myocardium / Q000473:pathology*; D012680:Sensitivity and Specificity